Legal Representation
Attorney
Cheryl Foytlin
USPTO Deadlines
Application History
24 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 8, 2020 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Jun 8, 2020 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Aug 31, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 29, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 29, 2019 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Aug 29, 2019 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Mar 1, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 27, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 27, 2019 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Feb 27, 2019 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Sep 7, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Sep 5, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 5, 2018 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Sep 5, 2018 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Mar 6, 2018 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Mar 6, 2018 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Mar 6, 2018 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Jan 9, 2018 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jan 9, 2018 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Dec 20, 2017 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Nov 30, 2017 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Nov 24, 2017 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 20, 2017 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Oct 16, 2017 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, pulmonary diseases, cardiovascular diseases, central nervous system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infection-related diseases, metabolic diseases, oncologic diseases, cerebrovascular diseases, ophthalmic diseases, and respiratory diseases; anti-allergics; vaccines
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005